Yirong Wu

Yirong Wu

Auto-generated profile, based on publicly available information

Yirong Wu

Department of the Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Epigenomics
Verified
Journal Article
Closed access
RHRong Huang
Rong Huang
YWYirong Wu
Yirong Wu
ZZZhengyun Zou
Zhengyun Zou
EZH2 is an epigenetic regulator that methylates lysine 27 on histone H3 (H3K27) and is closely related to the development and metastasis of tumors. It often shows gain-of-function mutations in hema... Plain language summary EZH2 is a histone methyltransferase whose high expression is associated with a poor prognosis in various solid tumors. It is considered a target for cancer treatment. However... Tweetable abstract Review describing EZH2 inhibitors combined with other antitumor therapy to provide therapeutic synergy for solid tumor treatment.

15 July 2025 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
RHRong Huang
Rong Huang
XSXinyu Su
Xinyu Su
JWJiayu Wang
Jiayu Wang
QSQi Sun
Qi Sun
DKDonglin Kang
Donglin Kang
ZZZhengyun Zou
Zhengyun Zou
Background: Intratumoral fungi have recently been implicated in cancer initiation and progression, with potential as biomarkers for predicting clinical outcomes and treatment response in patients with cancer. However, their role in acral melanoma (AM) has not been previously explored. Methods: We characterized the mycobiome in AM tumor tissues and adjacent non-tumor tissues. Differences in fungal communities between the two tissues, as well as the prognostic and diagnostic potential of intratumoral fungi, and their associations with the tumor microenvironment and clinicopathologic features, were evaluated through bioinformatics and biostatistical analyses. Results: Although some intratumoral fungi originated from adjacent tissues, AM tumors exhibited a distinct fungal composition characterized by altered species richness, community structure, and an increased Ascomycota-to-Basidiomycota ratio. Several fungal taxa were identified as potential diagnostic and prognostic biomarkers and showed significant correlations with clinical parameters and immune infiltration. Specifically, the CD68-high samples harbored greater fungal diversity and higher relative abundance of Endocarpon compared with CD68-low samples. Furthermore, fungi–bacteria interactions were characterized by significant negative correlations between their diversity, while positive interspecies interactions dominated the network. Conclusions: These findings underscore the potential role of the cancer mycobiome in AM and offer new insights into the tumor microenvironment and its implications for cancer prevention and therapy.